1. Home
  2. CSTL vs BH Comparison

CSTL vs BH Comparison

Compare CSTL & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$40.31

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Biglari Holdings Inc. Class B

BH

Biglari Holdings Inc. Class B

HOLD

Current Price

$460.58

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
BH
Founded
2007
1934
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CSTL
BH
Price
$40.31
$460.58
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$46.00
N/A
AVG Volume (30 Days)
331.6K
63.7K
Earning Date
02-26-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
7.91
Revenue
$343,530,000.00
$386,507,000.00
Revenue This Year
$2.54
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$690.28
Revenue Growth
10.15
6.87
52 Week Low
$14.59
$195.05
52 Week High
$42.18
$463.13

Technical Indicators

Market Signals
Indicator
CSTL
BH
Relative Strength Index (RSI) 57.91 84.24
Support Level $38.73 $346.56
Resistance Level $41.60 $364.95
Average True Range (ATR) 1.58 18.15
MACD -0.12 9.64
Stochastic Oscillator 62.75 98.31

Price Performance

Historical Comparison
CSTL
BH

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.

Share on Social Networks: